es > en

> Symposium of Palex in the LIV National Congress of Intensive Medicine SEMICUYC


Clinical Care Division of Palex Medical has organized a Symposium in the LIV National Congress of Intensive Medicine SEMICUYC 2019.

The LIV National Congress of Intensive Medicine SEMICUYC 2019 was held in Palma de Mallorca (June 9th – 12th ), which brought about 900 congressmen and national and international experts in intensive medicine and cutting-edge medical technology. This year we also shared the stage with the XLV National Congress of Intensive Nursing SEEIUC, substantially increasing the number of attendees interested in critical care.

SEMICYUC’s scientific program offered multiple conferences, workshops, demonstrations and symposia at the highest level. One of the most anticipated and attended was the Symposium organized by the division of Clinical Care of Palex Medical. In it, it was possible to learn from international and national speakers of reference, experts in the treatment of hyperinflammation and sepsis with hemaadsorption techniques.

Table’s moderation was led by the doctors, Dr. Jaume Baldirà, specialist in Intensive Medicine at the Hospital de Sant Pau i Santa Creu in Barcelona, ​​and coordinator of the Toxicology working group of the Spanish Society of Intensive Medicine; and Dr. Paula Ramírez, specialist in Intensive Medicine at the Polytechnic University Hospital of the Faith Hospital of Valencia, and vice president of the scientific committee of the Spanish Society of Intensive Medicine.

The first presentation, Cytokine Removal in Early Septic Shock, was given by Professor Zsolt Molnar, from the University Hospital of Szeged, Hungary, member of the European Society of Intensive Care and the European Society of Anesthesia. He presented the conclusions of the first randomized study in early sepsis by hemoperfusion in patients without the need for renal replacement therapy.

Next, Dr Juan Carlos Ruiz from Vall d'Hebrón Hospital in Barcelona, ​​coordinator of the research group for the Vall d'Hebrón Institute shock, coordinator of the sepsis code, co-director of the Sepsis biobank and president of its scientific committee, presented Precision. Role of Cytokine Hemoabsorption as Rescue Therapy in Refractory Sepsis.

Dr. Ruiz explained the current situation of these techniques within the scientific community and the protocol and type of patient in which they use hemoabsorption of cytokines. He also highlighted a recent case in the hospital, where the load of these molecules related to inflammation were shown in massive amounts and drastically reduced in only 6 hours of treatment with Cytsosorb.

The third paper was also carried out by Dr. Paula Ramírez from La Fe Hospital in Valencia, who focused the topic Beyond Sepsis in other pathologies similar to sepsis such as CRS or Cytokine Release Syndrome. A new  pathological entity that begins to be increasingly common in intensive care units. The success of some new oncological treatments that are proving to be very effective forces the Intensivists to prepare each time to combat the effects caused by the dreaded cytokine storms.
Finally Dr. Klaus Kogelmann, Head of the Department of Intensive Medicine and Anesthesia of the Emden University Hospital Germany and active member of the Sepnet Sepsis Research Group presented Cytosorb Use in Septic Shock: Timing, Dosing, Indications and Evaluation of a new Scoring System. The team of Dr. Kogelmann has made multiple publications on the use of Cytsosorb in critical patients and highlighted his new SCORE that facilitates evaluation of the patient, and therefore the possible indications and times when starting this therapy.

Other news

> Share in